Gensia Laboratories Ltd.: The Irvine subsidiary of...
- Share via
Gensia Laboratories Ltd.: The Irvine subsidiary of San Diego-based Gensia Inc. said Wednesday that it has received approval from the U.S. Food and Drug Administration to offer its injectable drug to treat lung cancer and testicular tumors in a one-gram glass vial. The company received approval for the drug in smaller sizes last year.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.